Applied Therapeutics Q1 2024 GAAP EPS $(0.67) Misses $(0.14) Estimate, Sales $190.000K Miss $3.333M Estimate
Portfolio Pulse from Benzinga Newsdesk
Applied Therapeutics reported its Q1 2024 earnings with a GAAP EPS of $(0.67), missing the $(0.14) estimate. Sales were $190,000, significantly below the $3.333 million estimate.
May 09, 2024 | 11:35 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied Therapeutics missed Q1 2024 earnings and sales estimates, with a significant gap in expected revenue.
Missing both EPS and sales estimates by wide margins suggests operational challenges or market conditions that could negatively impact investor confidence and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100